Companies / Glaukos Corporation
Glaukos Corporation
United States
Glaukos Corporation develops and leads the global ophthalmic market with novel therapies that advance the existing standard of care.
Glaukos Corporation, based in United States, has 1 investor on file, among them Versant Ventures. Its site was last checked 17 Nov 2026: site answers.
Investors
1 investor on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Venture capital |
In the news
1 headline naming Glaukos CorporationEach headline is matched with evidence and opens on its outlet. Some come through the GDELT Project.
More from Versant Ventures
60 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (95%), Robotics & Hardware (4%), AI & Machine Learning (4%).
See Versant Ventures' full profile · Who invests alongside it
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get Glaukos Corporation and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Versant Ventures adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/glaukos.com/investors
# also
GET /v1/companies/glaukos.com
GET /v1/companies/glaukos.com/news